EVQLV

EVQLV is a biotechnology company that leverages advances in computation to accelerate the design and development of therapeutic antibodies. Its proprietary computational platform generates diverse, fully-human antibodies, aiming to accelerate the speed that healing reaches patients. The company's platform is designed to make AI accessible to antibody scientists.